Left Ventricular Function After ST-Elevation Myocardial Infarction in Patients Treated With Primary Percutaneous Coronary Intervention and Abciximab or Tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)

American Journal of Cardiology

Volumn 103, Issue 6, 2009, Pages 785-790

  Taglieri, Nevio ^a   Saia, Francesco ^a   Guiducci, Vincenzo ^b   Tondi, Stefano ^c   Conrotto, Federico ^d   Marrozzini, Cinzia ^a   Rocchi, Guido ^a   Biagini, Elena ^a   Reggiani, Maria Letizia Bacchi ^a   Giacometti, Paola ^b   Piovaccari, Giancarlo ^e   Manari, Antonio ^b   Marzocchi, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c Ospedale di Baggiovara   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e OSPEDALE DEGLI INFERMI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE; TIROFIBAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONVALESCENCE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; ST ELEVATION MYOCARDIAL INFARCTION; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME; TYROSINE; VENTRICULAR FUNCTION, LEFT;

EID: 61349143698     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.11.029     Document Type: Article

References (16)

1. Valgimigli M., Campo G., Percoco G., Bolognese L., Vassanelli C., Colangelo S., de Cesare N., Rodriguez A.E., Ferrario M., Moreno R., et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA 299 (2008) 1788-1799
2. Marzocchi A., Manari A., Piovaccari G., Marrozzini C., Marra S., Magnavacchi P., Sangiorgio P., Marinucci L., Taglieri N., Gordini G., et al. Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty results of the Facilitated Angioplasty with Tirofiban or Abciximab (FATA) in ST-elevation myocardial infarction trial. Eur Heart J 29 (2008) 2972-2980
3. Santoro G.M., Valenti R., Buonamici P., Bolognese L., Cerisano G., Moschi G., Trapani M., Antoniucci D., and Fazzini P.F. Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol 82 (1998) 932-937
4. Claeys M.J., Bosmans J., Veenstra L., Jorens P., De Raedt H., and Vrints C.J. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 99 (1999) 1972-1977
5. Matetzky S., Novikov M., Gruberg L., Freimark D., Feinberg M., Elian D., Novikov I., Di Segni E., Agranat O., Har-Zahav Y., et al. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol 34 (1999) 1932-1938
6. van't Hof A.W., Liem A., de Boer M.J., Zijlstra F., and Zwolle Myocardial infarction Study Group. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 350 (1997) 615-619
7. Parodi G., Memisha G., Carrabba N., Signorini U., Migliorini A., Cerisano G., and Antoniucci D. Prevalence, predictors, time course, and long-term clinical implications of left ventricular functional recovery after mechanical reperfusion for acute myocardial infarction. Am J Cardiol 100 (2007) 1718-1722
8. Danzi G.B., Sesana M., Capuano C., Mauri L., Berra Centurini P., and Baglini R. Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function. Am J Cardiol 94 (2004) 35-39
9. Coller B.S. Potential non-glycoprotein IIb/IIIa effects of abciximab. Am Heart J 138 (1999) S1-S5
10. Engler R.L., Dahlgren M.D., Morris D.D., Peterson M.A., and Schmid-Schonbein G.W. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 251 (1986) H314-H323
11. Clements I.P., Christian T.F., Higano S.T., Gibbons R., and Gerh B.J. Residual flow to the infarct zone as a determinant of infarct size after direct angioplasty. Circulation 88 (1993) [part 1]:1527-1533
12. Iwakura K., Ito H., Kawano S., Shintani Y., Yamamoto K., Kato A., Ikushima M., Tanaka K., Kitakaze M., Hori M., Higashino Y., and Fujii K. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 38 (2001) 472-477
13. De Luca G., Suryapranata H., Ottervanger J.P., Hoorntje J.C., Gosselink A.T., Dambrink J.H., de Boer M.J., and van't Hof A.W. Postprocedural single-lead ST-segment deviation and long-term mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Heart 94 (2008) 44-47
14. Sciagra R., Parodi G., Migliorini A., Valenti R., Antoniucci D., Sotgia B., and Pupi A. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy. Am J Cardiol 97 (2006) 48-54
15. Neumann F.J., Blasini R., Schmitt C., Alt E., Dirschinger J., Gawaz M., Kastrati A., and Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 98 (1998) 2695-2701
16. Petronio A.S., Rovai D., Musumeci G., Baglini R., Nardi C., Limbruno U., Palagi C., Volterrani D., and Mariani M. Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty. Eur Heart J 24 (2003) 67-76